Logo image of RECT

RECTITUDE HOLDINGS LTD (RECT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:RECT - KYG7445R1011 - Common Stock

1.96 USD
-0.1 (-4.85%)
Last: 11/26/2025, 8:00:54 PM
1.91 USD
-0.05 (-2.55%)
After Hours: 11/26/2025, 8:00:54 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to RECT. RECT was compared to 82 industry peers in the Commercial Services & Supplies industry. RECT has an average financial health and profitability rating. RECT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year RECT was profitable.
RECT had a positive operating cash flow in the past year.
RECT Yearly Net Income VS EBIT VS OCF VS FCFRECT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 1M 2M 3M 4M

1.2 Ratios

With an excellent Return On Assets value of 12.48%, RECT belongs to the best of the industry, outperforming 95.12% of the companies in the same industry.
Looking at the Return On Equity, with a value of 22.02%, RECT belongs to the top of the industry, outperforming 89.02% of the companies in the same industry.
RECT has a better Return On Invested Capital (18.68%) than 93.90% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RECT is significantly above the industry average of 10.48%.
The last Return On Invested Capital (18.68%) for RECT is above the 3 year average (15.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.48%
ROE 22.02%
ROIC 18.68%
ROA(3y)9.54%
ROA(5y)N/A
ROE(3y)22.34%
ROE(5y)N/A
ROIC(3y)15.59%
ROIC(5y)N/A
RECT Yearly ROA, ROE, ROICRECT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 8.82%, RECT belongs to the top of the industry, outperforming 82.93% of the companies in the same industry.
RECT's Profit Margin has declined in the last couple of years.
RECT's Operating Margin of 11.09% is fine compared to the rest of the industry. RECT outperforms 76.83% of its industry peers.
RECT's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 36.03%, RECT is in line with its industry, outperforming 59.76% of the companies in the same industry.
In the last couple of years the Gross Margin of RECT has grown nicely.
Industry RankSector Rank
OM 11.09%
PM (TTM) 8.82%
GM 36.03%
OM growth 3Y-15.28%
OM growth 5YN/A
PM growth 3Y-9.82%
PM growth 5YN/A
GM growth 3Y4.69%
GM growth 5YN/A
RECT Yearly Profit, Operating, Gross MarginsRECT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RECT is creating value.
The number of shares outstanding for RECT has been reduced compared to 1 year ago.
Compared to 1 year ago, RECT has an improved debt to assets ratio.
RECT Yearly Shares OutstandingRECT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M
RECT Yearly Total Debt VS Total AssetsRECT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 3.95 indicates that RECT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.95, RECT is in the better half of the industry, outperforming 74.39% of the companies in the same industry.
RECT has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
RECT has a better Debt to Equity ratio (0.14) than 70.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 3.95
ROIC/WACC2.27
WACC8.22%
RECT Yearly LT Debt VS Equity VS FCFRECT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 2.26 indicates that RECT has no problem at all paying its short term obligations.
The Current ratio of RECT (2.26) is better than 76.83% of its industry peers.
RECT has a Quick Ratio of 1.64. This is a normal value and indicates that RECT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, RECT is in the better half of the industry, outperforming 69.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 1.64
RECT Yearly Current Assets VS Current LiabilitesRECT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M 15M 20M 25M

3

3. Growth

3.1 Past

RECT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.57%.
The Earnings Per Share has been growing slightly by 3.59% on average over the past years.
Looking at the last year, RECT shows a quite strong growth in Revenue. The Revenue has grown by 10.15% in the last year.
RECT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.68% yearly.
EPS 1Y (TTM)-16.57%
EPS 3Y3.59%
EPS 5YN/A
EPS Q2Q%-14.55%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y13.68%
Revenue growth 5YN/A
Sales Q2Q%9.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RECT Yearly Revenue VS EstimatesRECT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 10M 20M 30M 40M

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.76, the valuation of RECT can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of RECT indicates a rather cheap valuation: RECT is cheaper than 91.46% of the companies listed in the same industry.
RECT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.15.
Industry RankSector Rank
PE 6.76
Fwd PE N/A
RECT Price Earnings VS Forward Price EarningsRECT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RECT is valued cheaper than 93.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.91
RECT Per share dataRECT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

RECT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RECT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RECTITUDE HOLDINGS LTD

NASDAQ:RECT (11/26/2025, 8:00:54 PM)

After market: 1.91 -0.05 (-2.55%)

1.96

-0.1 (-4.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-31 2025-07-31
Earnings (Next)03-25 2026-03-25
Inst Owners0.36%
Inst Owner ChangeN/A
Ins Owners83.45%
Ins Owner ChangeN/A
Market Cap28.42M
Revenue(TTM)61.84M
Net Income(TTM)5.45M
AnalystsN/A
Price TargetN/A
Short Float %3.33%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.76
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF 184.36
P/B 1.49
P/tB 1.49
EV/EBITDA 3.91
EPS(TTM)0.29
EY14.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY0.54%
SpS3.29
BVpS1.32
TBVpS1.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.93
Profitability
Industry RankSector Rank
ROA 12.48%
ROE 22.02%
ROCE 21.73%
ROIC 18.68%
ROICexc 23.66%
ROICexgc 23.66%
OM 11.09%
PM (TTM) 8.82%
GM 36.03%
FCFM N/A
ROA(3y)9.54%
ROA(5y)N/A
ROE(3y)22.34%
ROE(5y)N/A
ROIC(3y)15.59%
ROIC(5y)N/A
ROICexc(3y)18.53%
ROICexc(5y)N/A
ROICexgc(3y)18.53%
ROICexgc(5y)N/A
ROCE(3y)18.14%
ROCE(5y)N/A
ROICexgc growth 3Y-20.65%
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.65%
ROICexc growth 5YN/A
OM growth 3Y-15.28%
OM growth 5YN/A
PM growth 3Y-9.82%
PM growth 5YN/A
GM growth 3Y4.69%
GM growth 5YN/A
F-Score5
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 0.39
Cap/Depr 32.39%
Cap/Sales 1%
Interest Coverage 28.51
Cash Conversion 2.28%
Profit Quality N/A
Current Ratio 2.26
Quick Ratio 1.64
Altman-Z 3.95
F-Score5
WACC8.22%
ROIC/WACC2.27
Cap/Depr(3y)16.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.57%
EPS 3Y3.59%
EPS 5YN/A
EPS Q2Q%-14.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y13.68%
Revenue growth 5YN/A
Sales Q2Q%9.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.13%
EBIT growth 3Y-3.69%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-110.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.24%
OCF growth 3Y-46.73%
OCF growth 5YN/A

RECTITUDE HOLDINGS LTD / RECT FAQ

Can you provide the ChartMill fundamental rating for RECTITUDE HOLDINGS LTD?

ChartMill assigns a fundamental rating of 5 / 10 to RECT.


What is the valuation status for RECT stock?

ChartMill assigns a valuation rating of 4 / 10 to RECTITUDE HOLDINGS LTD (RECT). This can be considered as Fairly Valued.


What is the profitability of RECT stock?

RECTITUDE HOLDINGS LTD (RECT) has a profitability rating of 6 / 10.


Can you provide the financial health for RECT stock?

The financial health rating of RECTITUDE HOLDINGS LTD (RECT) is 6 / 10.